Our Partners

Expertise Partners:

MT

myTomorrows

myTomorrows is a global health tech company dedicated to helping patients and physicians discover and access treatment options. We have partnered with 50+ Biopharma companies to support end-to-end expanded access program delivery, generate real-world data, and streamline clinical trial recruitment through the use of our proprietary AI technology. Our proactive, and stakeholder-focused approach combined with our operational excellence, innovation and adaptability ensures the best possible outcomes for patients, physicians, and our partners.

www.mytomorrows.com

WEP-WIth-Every-Patient-Logo-blue-300x142

WEP

At WEP, we are With Every Patient, as we believe every patient should have access to treatment.  With this as our guiding principle, we operate as a Complete CRO committed to delivering Clinical Trials, Expanded Access Programs, and Commercialization Solutions for Sponsors and patients worldwide. Our programs are delivered through High Quality, High Service, and High Value, returning a positive ROI to all Sponsors we have partnered with.

www.wepclinical.com

Event Partners:

inceptua_group_logo (1)

Inceptua Early Access

Inceptua Early Access is a global company specialising in the provision of Early Access Programs. With offices in 5 EU countries, the US, China and Japan, and a sophisticated global network of warehousing and shipping, Inceptua can supply medicines anywhere in the world. Inceptua has deep expertise in the setting up and running of complex group programs, post-trial access programs, exclusive distribution arrangements and market withdrawal scenarios. Our highly experienced management team provide unparalleled guidance and consulting services to support our clients in getting their medicines to patients in need, wherever they may be.

www.inceptua.com

Meda Systems

MedaSystems

MedaSystems' software is trusted by pharmaceutical companies across the United States and Europe to enhance patient outcomes and streamline the management of drugs under various pre-approval access pathways. Numerous major academic institutions actively use it, and our research and development efforts are grounded in thousands of hours spent collaborating with experts in global pre-approval access.

Life Science Companies use MedaSystems to:

  • Easily collaborate with healthcare providers
  • Make approval decisions faster
  • Reduce frustrating repetitive manual steps
  • Capture real-world data
  • Comply with regulations

www.medasystems.com